Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2018 | 1 |
2020 | 1 |
2021 | 1 |
2022 | 1 |
2023 | 2 |
2024 | 1 |
Search Results
6 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Megakaryopoiesis impairment through acute innate immune signaling activation by azacitidine.
J Exp Med. 2022 Nov 7;219(11):e20212228. doi: 10.1084/jem.20212228. Epub 2022 Sep 2.
J Exp Med. 2022.
PMID: 36053753
Free PMC article.
The NFIB-ERO1A axis promotes breast cancer metastatic colonization of disseminated tumour cells.
Zilli F, Marques Ramos P, Auf der Maur P, Jehanno C, Sethi A, Coissieux MM, Eichlisberger T, Sauteur L, Rouchon A, Bonapace L, Pinto Couto J, Rad R, Jensen MR, Banfi A, Stadler MB, Bentires-Alj M.
Zilli F, et al. Among authors: marques ramos p.
EMBO Mol Med. 2021 Apr 9;13(4):e13162. doi: 10.15252/emmm.202013162. Epub 2021 Mar 10.
EMBO Mol Med. 2021.
PMID: 33751828
Free PMC article.
Item in Clipboard
Sabatolimab plus hypomethylating agents in previously untreated patients with higher-risk myelodysplastic syndromes (STIMULUS-MDS1): a randomised, double-blind, placebo-controlled, phase 2 trial.
Zeidan AM, Ando K, Rauzy O, Turgut M, Wang MC, Cairoli R, Hou HA, Kwong YL, Arnan M, Meers S, Pullarkat V, Santini V, Malek K, Kiertsman F, Niolat J, Ramos PM, Menssen HD, Fenaux P, Miyazaki Y, Platzbecker U.
Zeidan AM, et al. Among authors: ramos pm.
Lancet Haematol. 2024 Jan;11(1):e38-e50. doi: 10.1016/S2352-3026(23)00333-2. Epub 2023 Dec 5.
Lancet Haematol. 2024.
PMID: 38065203
Clinical Trial.
Item in Clipboard
Azacitidine with or without eltrombopag for first-line treatment of intermediate- or high-risk MDS with thrombocytopenia.
Dickinson M, Cherif H, Fenaux P, Mittelman M, Verma A, Portella MSO, Burgess P, Ramos PM, Choi J, Platzbecker U; SUPPORT study investigators.
Dickinson M, et al. Among authors: ramos pm.
Blood. 2018 Dec 20;132(25):2629-2638. doi: 10.1182/blood-2018-06-855221. Epub 2018 Oct 10.
Blood. 2018.
PMID: 30305280
Free PMC article.
Clinical Trial.
Item in Clipboard
Next-generation sequencing of baseline genetic mutations and outcomes of eltrombopag and azacitidine therapy in patients with myelodysplastic syndromes and thrombocytopenia: Data from the SUPPORT clinical trial.
Ramos PM, Choi J, Campbell CD, Wang YA, Pallaud C, Dickinson M, Verma A, Mittelman M, Platzbecker U, Cherif H, Fenaux P.
Ramos PM, et al.
EJHaem. 2023 May 22;4(3):876-881. doi: 10.1002/jha2.694. eCollection 2023 Aug.
EJHaem. 2023.
PMID: 37601870
Free PMC article.
Item in Clipboard
Immune profiles in acute myeloid leukemia bone marrow associate with patient age, T-cell receptor clonality, and survival.
Brück O, Dufva O, Hohtari H, Blom S, Turkki R, Ilander M, Kovanen P, Pallaud C, Ramos PM, Lähteenmäki H, Välimäki K, El Missiry M, Ribeiro A, Kallioniemi O, Porkka K, Pellinen T, Mustjoki S.
Brück O, et al. Among authors: ramos pm.
Blood Adv. 2020 Jan 28;4(2):274-286. doi: 10.1182/bloodadvances.2019000792.
Blood Adv. 2020.
PMID: 31968078
Free PMC article.
Item in Clipboard
Cite
Cite